The IMPDH1 gene helps cells make guanine, a building block needed for DNA, RNA, and cell function, especially in the retina. If it does not work properly, the light sensing cells in the eye may gradually stop working well, which can cause night blindness, tunnel vision, and reduced sight over time. Some variants in the IMPDH1 gene are linked to inherited retinal conditions such as retinitis pigmentosa and, less often, vision loss beginning in childhood. Many variants are harmless, while a few may change how the gene supports the retina.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they occur, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
IMPDH1Gene function
What if the gene works
The IMPDH1 gene helps cells make one of the chemical building blocks needed for DNA and RNA. This supports normal cell growth and is especially important for the retina, the light sensing tissue at the back of the eye.
Risk
What if the gene does not work
Variants in the IMPDH1 gene mainly affect the retina, causing inherited vision loss such as retinitis pigmentosa or early-onset severe retinal disease. Effects can range from gradual night blindness to earlier, more marked sight loss, depending on the variant.
Treatment
What does that mean for your treatment
At present, no IMPDH1-specific treatment or drug choice is established in clinical guidelines for people with a pathogenic or loss-of-function variant in the IMPDH1 gene.
Conditions associated with IMPDH1
Gene function
What if the gene works
Inside your cells, the IMPDH1 gene supports a steady supply of important building blocks called guanine nucleotides. Its protein carries out a key step in making these molecules for everyday cell work. Understanding how the IMPDH1 gene works in the body helps explain how cells keep up with growth, repair, and routine activity.
The IMPDH1 gene helps cells make guanine nucleotides, small building blocks used throughout the body. Its protein changes IMP into XMP, a key step in the process that produces these molecules.
Guanine nucleotides are needed to make RNA and to support DNA production when cells grow or renew themselves. By maintaining this supply, the IMPDH1 gene helps cells copy genetic material and make working RNA messages.
Some guanine nucleotides help cells pass messages internally and keep many routine processes moving. This means the IMPDH1 gene supports day to day cell activity, including protein building and controlled cell growth.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Studies of how variants influence the IMPDH1 gene's function show that many disease linked changes alter the protein's shape, stability, or the way it joins with other copies inside retinal cells. These changes can disrupt enzyme control rather than simply turning it off. Some variants seem milder, while more disruptive variants can cause a bigger functional shift and are linked to earlier or more pronounced inherited retinal disease.
How variants are linked to conditions
Pathogenic variants in the IMPDH1 gene are linked to inherited retinal conditions, most notably autosomal dominant retinitis pigmentosa. In families with an IMPDH1 gene variant and retinitis pigmentosa, affected people often develop gradual vision loss, including trouble seeing at night and narrowing side vision. Some variants in the IMPDH1 gene have also been associated with severe early-onset retinal disease, including Leber congenital amaurosis.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For IMPDH1-related eye conditions, risk is mainly shaped by whether a disease-causing gene change is present in a family, rather than by lifestyle or common environmental factors. There is not enough evidence to say that diet, exercise, or other everyday habits lower the chance of developing the condition, although regular eye follow-up can help catch changes early.
Inheritance of IMPDH1 variants
For families looking into the IMPDH1 inheritance pattern, disease-causing changes in the IMPDH1 gene are most often inherited in an autosomal dominant way. This means a parent carrying the variant can pass it to a child of any sex, and each pregnancy has a 50% chance of inheriting that same variant. Sons and daughters are affected equally because the IMPDH1 gene is on chromosome 7, which is not a sex chromosome. In practice, the variant can pass from mother to child or father to child across generations.
What does my IMPDH1 result mean for my family?
For many living with an IMPDH1-related eye condition, the family pattern is usually dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same gene change. That can matter even when symptoms differ, since some family members may have milder or later-onset vision problems. The exact family impact depends on the specific IMPDH1 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
IMPDH1 genetic testing uses a blood or saliva sample to check the IMPDH1 gene for variants linked to inherited retinal conditions. If you need to work out how to find out about variants in the IMPDH1 gene, a lab reads the gene and compares it with known changes. Results may show a pathogenic, benign, or unclear variant.
When should I consider getting a genetic test?
Consider genetic testing for the IMPDH1 gene if you or close relatives have an inherited eye condition with early night blindness, loss of side vision, or gradually worsening eyesight, especially when it starts in childhood or runs in the family. Testing can help confirm whether IMPDH1 is the cause and support family planning and eye care follow-up.
A genetic result is only one part of your health story
Genetic test results can be informative, but what they reveal varies with the condition and the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, it can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body absorbs, breaks down, moves, or responds to drugs differently. These differences are common and can influence both how strongly a medicine works and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies gene drug patterns to help explain why the same treatment may work differently from one person to another. With many medications, genes can influence how the body handles a drug or how strong its effects are. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the IMPDH1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about symptoms, eye care, or medicines are best discussed with your doctor. Research has looked at whether IMPDH1 may affect response to mycophenolate, an immune-suppressing medicine, but this has not become routine guidance for care.
History
Research on the IMPDH1 gene gained momentum in the early 2000s, when scientists linked variants in this gene to a form of inherited retinal disease called retinitis pigmentosa. This was an important step because it connected a gene already known in basic cell biology with vision loss seen in families over generations. From these first observations, research expanded steadily, and later studies also linked IMPDH1 variants to some cases of early-onset severe retinal disease. The finding helped broaden ideas about which kinds of genes could be involved in eye conditions. Over time, descriptions became more precise as different IMPDH1 variants were tied to different patterns of retinal disease.